Abd El-Ghaffar Yosra S, Shouman Ahmed Esmat, Hakim Sally Adel, El Gendy Yasmin Gamal Abdo, Wahdan Maha Magdy Mahmoud
Community, Environmental and Occupational Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Paediatrics Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Glob Pediatr Health. 2022 Jun 17;9:2333794X221099266. doi: 10.1177/2333794X221099266. eCollection 2022.
Recurrent infections and weak immunity were found to be linked with zinc deficiency especially in children. The goal of this study is to measure the level of blood zinc in children aged 6 months to less than 5 years old, and to assess the effect of 4 months of daily zinc supplements on the incidence and the severity of diarrheal morbidity. A randomized controlled trial study was conducted in Pediatric Outpatient Clinic in Ain Shams University Hospital on 140 children less than 5 years old who are apparently healthy. Random assignment of the sampled children to group receiving zinc (70 children) or group receiving placebo (70 children) was done. A questionnaire containing questions about occurrence of diarrhea was used during follow up. Serum zinc at baseline was measured. The mean age was 25.26 ± 15.7 months. Mean of serum zinc was 51.08 μg/dL, with 70% had low baseline serum zinc level. Cumulative incidence of diarrhea, number of diarrhea episodes per child and frequency of stools/day decreased significantly in zinc group ( < .05). Risk ratio was found to be 0.79, 95% CI: 0.64 to 0.97. we concluded that incidence of diarrhea and its severity reduced in children received zinc daily for 4 months. This trial was registered at www.clinicaltrials.gov as NCT05002101.
研究发现,反复感染和免疫力低下与锌缺乏有关,尤其是在儿童中。本研究的目的是测量6个月至5岁以下儿童的血锌水平,并评估连续4个月每日补充锌对腹泻发病率和严重程度的影响。在艾因夏姆斯大学医院儿科门诊对140名明显健康的5岁以下儿童进行了一项随机对照试验研究。将抽样儿童随机分为接受锌补充剂组(70名儿童)和接受安慰剂组(70名儿童)。随访期间使用了一份包含腹泻发生情况问题的问卷。测量了基线时的血清锌。平均年龄为25.26±15.7个月。血清锌平均值为51.08μg/dL,70%的儿童基线血清锌水平较低。锌组腹泻的累积发病率、每个儿童的腹泻发作次数和每天的排便频率显著降低(<0.05)。风险比为0.79,95%置信区间:0.64至0.97。我们得出结论,连续4个月每日补锌的儿童腹泻发病率及其严重程度降低。该试验已在www.clinicaltrials.gov上注册,注册号为NCT05002101。